AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.73%132.980.7%$891.71m
PFEPfizer Inc.
0.70%36.560.9%$665.55m
MRKMerck & Co., Inc.
0.41%85.040.7%$648.50m
ABBVAbbVie, Inc.
1.27%74.702.3%$559.10m
BMYBristol-Myers Squibb Company
0.83%51.991.4%$509.35m
LLYEli Lilly and Company
1.65%109.681.0%$310.36m
NVSNovartis AG Sponsored ADR
0.92%86.720.2%$147.83m
AZNAstraZeneca PLC Sponsored ADR
0.79%44.191.2%$144.54m
GSKGlaxoSmithKline plc Sponsored ADR
0.32%42.310.3%$93.72m
SNYSanofi Sponsored ADR
1.52%45.570.2%$81.63m
NVONovo Nordisk A/S Sponsored ADR Class B
0.94%52.520.1%$72.50m
LCILannett Company, Inc.
3.65%11.2235.6%$16.60m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.24%1.751.6%$0.56m
EPIXESSA Pharma Inc
3.64%3.420.1%$0.10m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.